Back to calendar
BioCryst Pharmaceuticals, Inc. (BCRX) Earnings
BCRX reports earnings on Wednesday, November 4, 2026
earnings report
November 4, 2026
Q3 2026
Est. EPS: $0.09
Actual EPS: $0.14
EPS surprise: 52.40%
Company overview
Market Cap$1.9B
PriceUSD 7.43
EPS (TTM)-1.42
52-week high11.22
52-week low6.23
SectorHealth Technology
IndustryBiotechnology
Employees435